Comparison of Vaccination with Measles-Mumps-Rubella Vaccine at 9, 12, and 15 Months of Age
Open Access
- 1 May 2004
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 189 (Supplement) , S116-S122
- https://doi.org/10.1086/378691
Abstract
To determine seroconversion rates with measles-mumps-rubella vaccine administered to children at 9, 12, or 15 months of age, we undertook a prospectiKeywords
This publication has 18 references indexed in Scilit:
- Seroconversion of a trivalent measles, mumps, and rubella vaccine in children aged 9 and 15 monthsVaccine, 1997
- Molecular Epidemiology of Measles Virus: Identification of Pathways of Transmission and Implications for Measles EliminationThe Journal of Infectious Diseases, 1996
- Cellular Immunity in Measles Vaccine Failure: Demonstration of Measles Antigen-Specific Lymphoproliferative Responses despite Limited Serum Antibody Production after RevaccinationThe Journal of Infectious Diseases, 1995
- Antigenic Analysis Of Current Wild Type And Vaccine Strains Of Measles VirusThe Journal of Infectious Diseases, 1994
- Measles vaccine failuresThe Pediatric Infectious Disease Journal, 1994
- Measles Antibody: Reevaluation of Protective TitersThe Journal of Infectious Diseases, 1990
- Measles, mumps and rubella immunization at nine months in a developing countryThe Pediatric Infectious Disease Journal, 1990
- Transfer of Measles, Mumps, and Rubella Antibodies From Mother to InfantAmerican Journal of Diseases of Children, 1979
- Epidemic Measles in a Highly Vaccinated PopulationNew England Journal of Medicine, 1977
- Studies on immunity to measlesThe Journal of Pediatrics, 1965